Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer · Published 2026-04-01 · DOI 10.1016/j.clgc.2026.102557

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clgc.2026.102557

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad Test · Clinical Genitourinary Cancer · 2026 · Same journal
• Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System · Clinical Genitourinary Cancer · 2026 · Same journal
• Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review · Clinical Genitourinary Cancer · 2026 · Same journal
• Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma · Clinical Genitourinary Cancer · 2026 · Same journal
• Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report · Clinical Genitourinary Cancer · 2026 · Same journal
• Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Variant Histology Bladder Cancer: A Multi-institutional Propensity Score-Matched Analysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications · Clinical Genitourinary Cancer · 2026 · Same journal
• Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease · Clinical Genitourinary Cancer · 2026 · Same journal
• Treatment Patterns and Survival Outcomes in a Real-World Cohort of Lutetium 177 Vipivotide Tetraxetan (LuPSMA)-Experienced Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) · Clinical Genitourinary Cancer · 2026 · Same journal